Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhiqiang Meng
Observed names:
Z. Meng,
Z.-Q. Meng,
Z.Q. Meng,
Zhi-Qiang Meng,
Zhi-qiang Meng
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
The University of Texas MD Anderson Cancer Center,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0000-0001-7550-3129
Observed ORCID:
0000-0001-7550-3129
OpenAlex ID:
A5103099864
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial
2020
·
Feng Wang
, Shukui Qin
, et al.
·
Journal of Hematology & Oncology
·
153
PDF
Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study.
2022
·
Shukui Qin
, Zhendong Chen
, et al.
·
Journal of Clinical Oncology
·
122
Integrated Multi-Omics Landscape of Liver Metastases
2022
·
Shuai Yang
, Ling Qian
, et al.
·
Gastroenterology
·
120
Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition)
2018
·
Xin Ye
, Weijun Fan
, et al.
·
Journal of Cancer Research and Therapeutics
·
106
Expert consensus workshop report: Guidelines for thermal ablation of thyroid tumors (2019 edition)
2020
·
Dong Xu
, Minghua Ge
, et al.
·
Journal of Cancer Research and Therapeutics
·
75
Immunomodulatory effects of ablation therapy on tumors: Potentials for combination with immunotherapy
2020
·
Ling Qian
, Yehua Shen
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
44
Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response
2022
·
Yalei Zhang
, Ling Qian
, et al.
·
Molecular Therapy — Oncolytics
·
37
PDF
Randomized, placebo‐controlled trial of K1 acupoint acustimulation to prevent cisplatin‐induced or oxaliplatin‐induced nausea
2014
·
Yehua Shen
, Luming Liu
, et al.
·
Cancer
·
37
PDF
A randomized, double-blinded, phase III study of icaritin versus huachashu as the first-line therapy in biomarker-enriched HBV-related advanced hepatocellular carcinoma with poor conditions: Interim analysis result.
2021
·
Yan Sun
, Shukui Qin
, et al.
·
Journal of Clinical Oncology
·
35
A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment
2018
·
S.K. Qin
, Z.G. Ren
, et al.
·
Annals of Oncology
·
33
Tebotelimab, a PD-1/LAG-3 bispecific antibody, in patients with advanced hepatocellular carcinoma who had failed prior targeted therapy and/or immunotherapy: An open-label, single-arm, phase 1/2 dose-escalation and expansion study.
2023
·
Zhenggang Ren
, Yabing Guo
, et al.
·
Journal of Clinical Oncology
·
28
CMTM8 as an LPA1-associated partner mediates lysophosphatidic acid-induced pancreatic cancer metastasis
2021
·
Weidong Shi
, Chenyue Zhang
, et al.
·
Annals of Translational Medicine
·
26
Expert consensus on the multidisciplinary diagnosis and treatment of multiple ground glass nodule-like lung cancer (2024 Edition) ∆
2024
·
Baodong Liu
, Xin Ye
, et al.
·
Journal of Cancer Research and Therapeutics
·
21
Potent induction of antitumor immunity by combining cryo‐thermal ablation with immune checkpoint inhibitors in hepatocellular carcinoma
2023
·
Ling Qian
, Lin Xie
, et al.
·
Liver International
·
19
[Expert Consensus for Thermal Ablation of Pulmonary Subsolid Nodules (2021 Edition)].
2021
·
Xin Ye
, Weijun Fan
, et al.
·
PubMed Central
·
19
PDF
Clinical study of transarterial chemoembolization combined with 3-dimensional conformal radiotherapy for hepatocellular carcinoma
2011
·
L.-T. Xu
, Z.-H. Zhou
, et al.
·
European Journal of Surgical Oncology
·
18
The Molecular Mechanisms of Traditional Chinese Medicine ZHENG Syndromes on Pancreatic Tumor Growth
2010
·
Hai-Yan Dai
, Peng Wang
, et al.
·
Integrative Cancer Therapies
·
18
SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer
2024
·
Jin Li
, Yuxian Bai
, et al.
·
Cancer Immunology Immunotherapy
·
17
PDF
Predictive role of the monocyte-to-lymphocyte ratio in advanced hepatocellular carcinoma patients receiving anti-PD-1 therapy
2021
·
Zhen-Feng Zhu
, Li-Ping Zhuang
, et al.
·
Translational Cancer Research
·
17
PDF
Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma
2025
·
Shuichiro Shiina
, Ryosuke Tateishi
, et al.
·
Liver Cancer
·
14
Traditional Chinese medicine syndromes distribution in colorectal cancer and its association with Western Medicine Treatment and Clinical Laboratory Indicators
2019
·
Shi-Bing Su
, Meng-Die Yang
, et al.
·
World Journal of Traditional Chinese Medicine
·
14
Unresectable hepatocellular carcinoma: transarterial chemoembolisation plus Huachansu – a single-center randomised controlled trial
2023
·
Huifeng Gao
, Jian He
, et al.
·
BMJ Supportive & Palliative Care
·
11
PDF
Single-cell transcriptome analysis revealed the immune profile of PD-1 blockade in gallbladder carcinoma liver metastasis
2023
·
Lin Xie
, Zhouyu Ning
, et al.
·
Hepatology Communications
·
11
exoRBase 3.0: an updated resource for extracellular RNAs from human biofluids
2025
·
Wenqian Yu
, Jia Hu
, et al.
·
Nucleic Acids Research
·
10
PDF
Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy
2024
·
Changjing Huang
, Chien-shan Cheng
, et al.
·
BMC Cancer
·
8
PDF
Show more works
View as search
Works count:
46
Citation count:
1,039
H-index:
17
I10-index:
24
Year
Topic
Type